Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.
Armani E, Rizzi A, Iotti N, Saccani F, Di Lascia MR, Tigli L, Pappani A, Marchini G, Murgo A, Capelli AM, Delcanale M, Puccini P, Villetti G, Civelli M, Beato C, Giuliani M, Mundi C, Murarolli F, Pagano M, Raveglia LF, Remelli R, Amari G. Armani E, et al. Among authors: civelli m. J Med Chem. 2023 Apr 27;66(8):5622-5656. doi: 10.1021/acs.jmedchem.2c02087. Epub 2023 Apr 5. J Med Chem. 2023. PMID: 37017110
Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.
Rizzi A, Amari G, Pivetti F, Delcanale M, Amadei F, Pappani A, Fornasari L, Villetti G, Marchini G, Pisano AR, Pitozzi V, Pittelli MG, Trevisani M, Salvadori M, Cenacchi V, Fioni A, Puccini P, Civelli M, Patacchini R, Baker-Glenn C, Van de Poël H, Blackaby W, Nash K, Armani E. Rizzi A, et al. Among authors: civelli m. J Med Chem. 2023 Aug 24;66(16):11476-11497. doi: 10.1021/acs.jmedchem.3c01012. Epub 2023 Aug 10. J Med Chem. 2023. PMID: 37561958
Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes.
Bonatti M, Pitozzi V, Caruso P, Pontis S, Pittelli MG, Frati C, Mangiaracina C, Lagrasta CAM, Quaini F, Cantarella S, Ottonello S, Villetti G, Civelli M, Montanini B, Trevisani M. Bonatti M, et al. Among authors: civelli m. BMJ Open Respir Res. 2023 Sep;10(1):e001476. doi: 10.1136/bmjresp-2022-001476. BMJ Open Respir Res. 2023. PMID: 37730279 Free PMC article.
CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder.
Martucci C, Allen AD, Moretto N, Bagnacani V, Fioni A, Patacchini R, Civelli M, Villetti G, Facchinetti F. Martucci C, et al. Among authors: civelli m. Front Pharmacol. 2024 Mar 14;15:1343941. doi: 10.3389/fphar.2024.1343941. eCollection 2024. Front Pharmacol. 2024. PMID: 38549671 Free PMC article.
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.
Carzaniga L, Linney ID, Rizzi A, Schmidt W, Knight CK, Mileo V, Amadei F, Pastore F, Miglietta D, Cesari N, Riccardi B, Mazzucato R, Ghidini E, Blackaby WP, Patacchini R, Battipaglia L, Villetti G, Puccini P, Catinella S, Civelli M, Rancati F. Carzaniga L, et al. Among authors: civelli m. J Med Chem. 2024 Jun 27;67(12):9816-9841. doi: 10.1021/acs.jmedchem.4c00298. Epub 2024 Jun 10. J Med Chem. 2024. PMID: 38857426
Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder.
Martucci C, Allen AD, Moretto N, Bagnacani V, Fioni A, Patacchini R, Civelli M, Villetti G, Facchinetti F. Martucci C, et al. Among authors: civelli m. Front Pharmacol. 2024 Oct 25;15:1497520. doi: 10.3389/fphar.2024.1497520. eCollection 2024. Front Pharmacol. 2024. PMID: 39525638 Free PMC article.
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 Inhibitors.
Pala D, Ronchi P, Rescigno D, Bertani B, Capelli AM, Guariento S, Marchini G, Milioli M, Cesari N, Federico G, Grandi A, Stellari FF, Fernandez SX, Pappani A, Venturi L, Biagetti M, Civelli M, Semeraro T, Bianchi F, Trist IML, Remelli R, Armani E, Pizzirani D. Pala D, et al. Among authors: civelli m. ACS Med Chem Lett. 2024 Oct 23;15(11):1925-1932. doi: 10.1021/acsmedchemlett.4c00374. eCollection 2024 Nov 14. ACS Med Chem Lett. 2024. PMID: 39563792
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.
Carzaniga L, Linney ID, Rizzi A, Delcanale M, Schmidt W, Knight CK, Pastore F, Miglietta D, Carnini C, Cesari N, Riccardi B, Mileo V, Venturi L, Moretti E, Blackaby WP, Patacchini R, Accetta A, Biagetti M, Bassani F, Tondelli M, Murgo A, Battipaglia L, Villetti G, Puccini P, Catinella S, Civelli M, Rancati F. Carzaniga L, et al. Among authors: civelli m. J Med Chem. 2022 Aug 11;65(15):10233-10250. doi: 10.1021/acs.jmedchem.2c00609. Epub 2022 Jul 28. J Med Chem. 2022. PMID: 35901125
114 results